Clinical Trials Browser

Phase 2 × Dendritic Cell Sarcoma, Interdigitating × pembrolizumab × Clear all

Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Dendritic Cell Sarcoma, Follicular, Histiocytic Sarcoma

NCT03349450 2023-11-02

SPiReL

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Clinical Trials

Pembrolizumab in Neoplasms or Lymphomas

SPiReL